We then performed quantitative PCR (qPCR), Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) on Aβ-treated immortalized and primary microglia and macrophage cell cultures, to assess Cxcl16 expression levels in in vitro AD-like conditions. Here, CXCL16 is linked to Alzheimer disease.